Podcasts about helsinki university

In this episode, we're looking at research from an interdisciplinary network named COSY, funded by the European Cooperation in Science and Technology (COST) agency. Their workgroup researching ‘Confined systems in Astrochemistry' is led by Professors Lauri Halonen from Helsinki University in Finland and Malgorzata Biczysko from Wroclaw University in Poland. They are engaged in laboratory and computational experiments on new molecules detected in the interstellar medium. Visit their site: https://cost-cosy.eu/

In this Episode I welcome on Sami Inkinen CEO of Virta Health to discuss Virta Health's approach to Type 2 Diabetes reversal' Virta Health utilizes a continuous remote care intervention (CCI) that incorporates individualized carbohydrate restriction, health coaching, and telemedicine to manage and reverse Type 2 Diabetes We cover topics such as: Impact of individualized carbohydrate restriction: The role of the patient-provider relationship: Addressing quality of food The Virta change model: GLP-1 Receptor agonists as a bridge: Sustainable solutions require addressing nutrition: Research Findings of Virta's approach. Long-Term Effects of CCI: A 2-year non-randomized clinical trial published in Frontiers in Endocrinology showed significant and sustained improvements in multiple clinical markers of diabetes and cardiometabolic health in the CCI group compared to the UC (usual care) group . These included reductions in HbA1c, fasting glucose and insulin, weight, blood pressure, triglycerides, and liver alanine transaminase . The CCI group also saw higher rates of diabetes reversal and remission . GLP-1 Deprescription: A recent study published in Diabetes Therapy explored the impact of discontinuing GLP-1 agonists in patients who had successfully integrated Carb-Restriction Nutrient Therapy (CRNT) supported by Virta's telemedicine model . The study found that patients did not experience weight regain after stopping GLP-1 medications, and while HbA1c levels increased slightly, they generally remained below the diagnostic threshold for diabetes About Sami: Join NowSami InkinenFounder, Chief Executive Officer Sami Inkinen is the Chief Executive Officer and Co-Founder of Virta Health, the leader in diabetes reversal and sustainable weight loss. With a combination of proven nutrition, expert support, and advanced technology, Virta empowers members with the tools and knowledge to sustain changes for a longer, healthier life. A data-driven technology entrepreneur, Sami's personal experience with diabetes and passion to advance global health was the motivation behind Virta. Working with over 500 large employers, health plans, and government organizations across the country, Virta has helped over 100,000 members reverse their diabetes and obesity. Previously, Sami was co-founder of leading online real estate marketplace Trulia, serving as its COO, president, and board member until its IPO and eventual sale to Zillow Group, and held roles at Microsoft and McKinsey & Company. He also founded Fat Chance Row to raise awareness of the dangers of sugar and its connection to diabetes, rowing from California to Hawaii — 2,750 miles — with his wife, completely unsupported.  He holds a MS in engineering physics from the Helsinki University of Technology and a MBA from Stanford University, and is also a triathlon age group world champion and 8 hour 24 minute Ironman finisher, having completed seven Hawaii Ironmans. He lives in Colorado with his wife and two daughters, enjoying the outdoors and the delight of their small barn of egg-laying chickens. Socials Website: https://www.virtahealth.com/Instagram: https://www.instagram.com/virtahealth/?hl=enFacebook: https://www.facebook.com/virtahealth/Linkedin: https://www.linkedin.com/company/virta-healthYouTube: https://www.youtube.com/virtahealthX: https://x.com/virtahealth --- Support this podcast: https://podcasters.spotify.com/pod/show/onethingpod/support

Jaakko Björklund from Helsinki University tells the story of mutiny and unrest in the Swedish Army during the Ingrian War against Muscovy in 1609-1617. He identifies the sources of disconent among the domestic and foreign troups, it's expressions, and explains how it was handled by the officers. This is a story of army (in)discipline in the time when Sweden went from supporting the Muscovite state to campaigning to absorb chunks of its territory.

Roie Galitz (born 1980) is an award-winning, NYC based, wildlife photographer and entrepreneur. For over a decade, he has been exploring and documenting our planet's wildlife and nature, from the Arctic to the Antarctic. His intimate and innovative work (BBC, Nat Geo) gets great exposure worldwide, millions of views and frequent appearances in the media. It was presented in local and international exhibitions, featured in exclusive magazines and honored with over 70 international awards, including the prestigious Picture of the Year for reportage of Science and Natural History. With equal passion and commitment, Roie is acting as a Greenpeace ambassador and engaging in conservation work around the globe. His video and still photography is a strong testimony to the struggle of the majestic animals he meets throughout his expedition, under the threats of climate change . To help protect them, he shares their stories in fascinating talks. He is recognized for his talks at the United Nations HQ, the NYC Climate Week and TEDx talks in Helsinki University, Glasgow and Wexford alongside global conventions everywhere. In his homeland of Israel, Roie is a leading figure in the field of photography and was named to The Marker's magazine 40 under 40 list. He shares his knowledge and passion with tens of thousands of photography lovers at the establishments he founded: Galitz School of Photography; largest photography school in Israel (founded 2007), Phototeva Expeditions; one of the world's top 10 photography expeditions companies (Founded 2010), Composition Magazine; Israel's most popular photography magazine (Founded 2009), and the Annual Israeli Photography Convention (Founded 2008). Roie is an Explorer, member of the Explorers Club and is a board member of the Israeli Nature and Heritage Foundation

Roope Rainisto is a Finnish designer, creator, photographer and screen-writer with a flair for storytelling. Roope has had a lengthy career as a professional designer, and holds a Master of Science degree in Information Networks from the Helsinki University of Technology, Through his art, he combines artificial intelligence and traditional art methods to blur the boundary between the real and the virtual, creating works that feels both familiar and foreign. Acclaimed collections include Life in West America, Reworld, and the recently released Vacation series.Recorded on June 7, 2024 as a Space on X.Follow the guest:https://twitter.com/rainistoFollow the host:https://twitter.com/0x_ScooterFollow Particle:https://twitter.com/Collectparticlehttps://www.particlecollection.comhttps://www.instagram.com/particlecollectionTimestamps:(00:00) Introduction(01:56) Self Expression through Creative Pursuits(03:39) Impact of Design Career on Artistic Trajectory(05:55) Taking Risks & Avoiding Regret through Art(08:55) Developing User Experience Patent Applications(11:24) Influence of AI on the Role of the Artist(14:33) Establishing Authenticity in an Artistic Practice(18:30) Questions of Originality & Authorship in AI(22:16) Perception & Reality in AI Photography(26:11) Examining Individual Drama through Life in West America (29:50) Shoshin, or the Beginner's Mind, Reflected through AI(33:58) Exploring our Place in Society with Reworld(36:38) "Introspection" and the Representation of Reality in Art(38:13) Curating Post Photographic Perspectives with FellowshipAI(40:45) Investigating Escapism through Vacation series(43:38) Human Desire for Unique Experiences(46:03) Using AI to Create Drama & Disruption(49:20) Roope's Approach to Collecting Art (52:03) Approach to Curating Works for Collections(54:12) Outro

Michael sits down this week with Lauri Myllyvirta, co-founder and lead analyst at CREA - the Centre for Research on Energy and Clean Air. After working as a campaigner and then as an analyst at Greenpeace, Lauri helped set up CREA, an NGO that produces research reports on the trends, causes, health impacts, and solutions to air pollution. Importantly, CREA makes extensive reference to local-language evidence sources - helped by Lauri's impressive knowledge of European and Asian languages. Lauri has degrees in economics from Helsinki University and in environmental science from University of Jyvaskyla.    Links  Read the BBC's recent articles highlighting CREA's research on the UK's Russian oil sanctions: https://www.bbc.co.uk/news/business-68018660 And read the original CREA report here: https://energyandcleanair.org/publication/evading-the-sanctions-uk-imports-oil-products-made-from-russian-crude/ Read CREA's report on the surge in coal power in China in 2023: https://energyandcleanair.org/publication/chinas-new-coal-power-spree-continues-as-more-provinces-jump-on-the-bandwagon/ Read CREA's report on the health impacts of delaying coal decommissioning in South Africa: https://energyandcleanair.org/publication/health-impacts-of-delaying-coal-power-plant-decommissioning-in-south-africa/ Read CREA's report on the recent spree of coal plant permitting in India: https://energyandcleanair.org/publication/india-enters-an-unnecessary-coal-plant-permitting-spree-in-2023/ Read CREA's report on the state of Indonesia's transition: https://energyandcleanair.org/publication/emerging-captive-coal-power-in-indonesia/ Explore all of CREA's reports here: https://energyandcleanair.org/publications/

Jimena Califa (UN Global Pulse), Andrea Botero Cabrera (Aalto University) and Florencia Quesada- Avendaño (Helsinki University) reflect on decolonial practices in design, research and education. The panel took place in Aalto University, in Finland. This panel was an initiative of SUR collective, a group of students and researchers striving for decolonial practices and aiming to respond to the hegemonic narratives of the North. This panel opens a discussion about the issue of decolonizing design education and practices within the Finnish context, with insights from active educators and professionals from the Global South. The central concern revolves around the possibility of integrating decolonial practices into the teaching and designing in Finland. This concern is rooted in the experiences of Latinx students at Aalto University's ARTS school, who have observed a marked absence of Non-Western perspectives, notably in areas such as sustainability. The panel explore the challenges, possibilities, and implications of incorporating decolonial approaches into Finnish university education. This panel is part of the list: Investigación en diseño, Finlandia y diseño, Sin Fronteras and Educación en diseño.

In the 13th episode of  A is for Architecture's third series, I spoke with the remarkable architect and writer, Juhani Pallasmaa, former professor of architecture and dean at the Helsinki University of Technology, now incorporated as Aalto University. Pallasmaa's work has been of huge importance to architects now active in the transformation of our towns and cities, with his description of a tactile, material and immanent embodiment visible in the work of almost all good, urban work now being built. His written work particularly stands, in a way, in counterpoint to the superficial and the visual, that occularcentric tendency born of late capitalist starcitecture, and the preferencing of the image over depth and the experiential. Central to our discussion were two of Pallasmaa's great works – The Eyes of the Skin (John Wiley & Sons, 1996) and The Thinking Hand (John Wiley & Sons, 2009), both of which are worthy of continued study. You can listen to Jonathan Hale speak about Juhani's inspiration, the phenomenologist philosopher Maurice Merleau-Ponty, on A is for Architecture here. Before he and I recorded this episode, Juhani had received a Lifetime Achievement Award by the Paimio Sanatorium Foundation, at the Sanitorium itself, where he also gave a talk entitled "The Ethical Meaning of Architecture: The relational and existential essence of art". A joy and an undeserved privilege, getting to speak to a hero like this. Available on Spotify, iTunes, Google Podcasts and Amazon Music. Thanks for listening. + + + + + + + + + + + + + + + Music credits: Bruno Gillick + + + + + + + + + + + + + + + aisforarchitecture.org Apple: podcasts.apple.com Spotify: open.spotify.com Google: podcasts.google.com Amazon: music.amazon.co.uk

It is not always easy for children and young people to get their voices heard when it comes to the planning of the cities they live in. But their input is important for a whole range of reasons including that cities need to be fit for purpose, young people's health and counteracting climate change.In this third episode, a student from Helsinki University, Gaëtan Gamba, and a recent alumni of Södertörn University, Jasmin Adolph, speak to two researchers, Romina Rodela from Södertörn University, and Natalie Gulsrud from the University of Copenhagen, about urban planning and youth involvement.  This podcast was made possible by funding from the A.P. Moller Foundation.Go to The New Nordic Lexicon for further reading on this and many more subjects!Sound credits: Summer by tictac9 from freesound.org.Follow us on Instagram, Facebook, and Twitter.

Many high-profile companies these days are reflections of their superstar CEOs – people like Elon Musk and Jamie Dimon. Author Thomas Keil suggests that although they may be good for branding, just like regular rock stars, they can't truly do it alone.His new book, co-authored with Marianna Zangrillo, is entitled The Next Leadership Team: How to Select, Build, and Optimize Your Top Team, and is available at Amazon and elsewhere.Thomas Keil, D.Sc. (Tech.)Thomas professional aim is to bridge the divide between academia and practice.He is a Full Professor at the University of Zurich, Switzerland where he teaches strategy and international management. Thomas holds a D.Sc. (Tech.) and Lic. Tech. from Helsinki University of Technology and a Dipl. Wirtsch. Ing from TH Darmstadt. Previously he taught at the Schulich School of Business at York University in Canada and at Aalto University in Finland.Thomas' research focuses on the senior leader's agenda in multinational corporations, specifically board design, CEO succession, leadership teams, transformation, mergers and acquisitions, and strategy. His research has won several awards and has been published in leading practitioner journals, including the Harvard Business Review and the MIT Sloan Management Review in addition to top academic journals.Thomas is a partner in The Next Advisors a consulting firm advising CEOs, executives, and boards of small and large corporations across a wide range of industries. As an internationally recognized authority on CEO, leadership, and strategy topics, he has taught executives from Asia, Europe, and North America and is a regular keynote speaker.Marianna Zangrillo, D.Sc. (Tech.)Born in 1974, Marianna is a transformational leader, a business angel and an author.She has spent the past 20 years working in senior roles across industries, where she has been driving significant transformation initiatives to drive operational excellence, higher ROI and increased corporate performance. In those roles, Marianna has led teams and projects in Europe, Middle East, Asia and North America.Marianna has been teaching at leading European universities including Aalto University and the University of Zurich and has been a keynote speaker at various practitioners' conferences.In addition, she has conducted research on boards, CEO succession, leadership teams, and board design which has been published in MIT Sloan Management Review, LSE Business Review, I by IMD, her book “The Next CEO” and her new book “The Next Leadership Team”.Marianna holds a Master of Laws (Italy, 1999), a LLM in Contract and Commercial Law (Finland, 2000), a MBA in International Management (U.K., 2005) and a PhD in Supply Chain Management (Finland, 2017).Marianna is a partner in The Next Advisors where she advises to CEOs, executives, and boards members in multiple industries.

0:00 - The NYPD and US Secret Service are huddling to prep for Donald Trump's possible indictment in Manhattan   13:14 - President Trump posted a retrospective on six years of Democrat investigations against him on Truth Social 30:09 - Greta Thunberg awarded honorary doctorate in theology from Helsinki University   49:49 - Is your pantry organized? Bad news, that means you're racist and sexist according to a Loyola professor   01:06:22 - Andrew McCarthy is a Former Chief Asst. U.S. Attorney & Contributing Editor at National Review and author of Ball of Collusion: The Plot to Rig an Election and Destroy a Presidency. He joined Dan and Amy with reaction to the potential indictment of former President Trump.   01:26:57 - Stephen Moore is a noted economist and author of Govzilla: How the Relentless Growth of Government Is Devouring Our Economy—And Our Freedom. He joined Dan and Amy with reaction to Janet Yellen's comments that the US banking system is stabilizing   01:42:40 - Amber Athey is the Washington Editor for The Spectator and host of the “Unfit to Print” podcast. She joined Dan and Amy to talk about her new book "The Snowflakes' Revolt: How Woke Millennials Hijacked American Media"   01:54:49 - Dirty tricks revealed in D86 school board race as Akhras campaigner resignsSee omnystudio.com/listener for privacy information.

Elina Reponen, MD, Ph.D., Chief Anesthesiologist at the Helsinki University Hospital, shares with us about her experience in Finland using the self-assessment instrument for Lean implementation in a healthcare system that was developed by CLEAR (the Center for Lean Engagement and Research).

Over the years, there has been good evidence that certain treatments are of little or no value, provide harm and have substantial costs associated with them. Arthroscopic partial meniscectomy (APM) is not a recommended treatment for osteoarthritis. Despite this, millions of these procedures are still being performed each year. On this week's episode of Joint Action we are joined by Professor Teppo Järvinen to discuss the evidence behind APM and evidence-based medicine.Professor Teppo Järvinen, an orthopaedic surgeon at the department of orthopaedics and trauma at Helsinki University and Helsinki University Central Hospital. Teppo led the Fidelity trial and has a strong interest in the “too much medicine” movement.CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Spencer speaks with Sami Inkinen, the CEO and Founder of Virta Health. After winning the Ironman 70.3 World Championships in 2011, the triathlete found out that he was pre-diabetic that same year. Unsatisfied with the conventional wisdom of “exercise more and eat less,” Sami dug into the science of type 2 diabetes, by consulting experts on the science of carbohydrate restriction and metabolic health. Seeking to raise awareness about the dangers of sugar, Inkinen and his wife rowed across the Pacific Ocean for 45 days—completely unsupported—from California to Hawaii for 2,750 miles. While on that journey, the idea for Virta was born. His personal mantra on that trip was "Use Sisu, not Sugar"—with the Finnish concept of Stoicism, tenacity, and grit, as determination to help himself and others reverse their diagnoses.  Virta is an app-based, health technology start-up that offers treatment to reverse type 2 diabetes without surgery, allowing patients to work with medical providers and health coaches on a nearly real-time basis. Virta's approach helps patients get off of all diabetes-specific medications while achieving sub-diabetic HbA1c (blood sugar)—in 60% of patients who complete one-year of the Virta Treatment. Of those patients prescribed insulin, 94% reduce or fully-eliminate usage.  Previously, Inkinen was the co-founder of real estate marketplace Trulia, serving as its COO and president and board member until its IPO and sale to Zillow Group. Sami is also an active angel investor in healthcare. Inkinen started his career as a radiochemist at a nuclear power plant. He holds a Master of Science in engineering physics from the Helsinki University of Technology, and a Master of Business Administration from Stanford University. 

The inside of the earth's pretty hot. How hot? As hot as the surface of the sun. Seriously.  That heat could generate unbelievable amounts of clean geothermal energy to power our civilization—if we could reach all the way down there. You see, to get to fossil fuels like oil and gas, we only need to drill down a couple kilometers. In places that have volcanoes, like Iceland, you can fairly easily reach down into hellish parts of the earth to harness geothermal energy, but most human populations tend not to be crowded around active volcanoes for obvious reasons.  In the places where power plants typically exist—near human civilization—we'd need to drill more like 10-20 kilometers down, which just isn't really possible with conventional drilling techniques.  Enter Quaise Energy, a four-year-old startup that's raised $70 million so far to drill deeper than humans have ever gone. Their plan isn't to use mechanical drill bits, which are limited in their utility at such deep depths, but rather to vaporize rock using microwaves.  Their plan is as bold as it is simple: Drill thousands of these eight-inch-wide but super-deep holes right next to existing power plants. That way, the plants can run on geothermal energy and stop using coal to create the energy we all use daily.  If it works, it's a rapidly scalable solution to quickly slash our fossil fuel use and avert the most catastrophic climate scenarios. Our guest in this episode is Quaise Energy's CFO, Kevin Bonebreak, a guy who spent most of his career in the conventional energy investment world, and is now working to bring about a cleaner, safer, and saner way to power human civilization.  Discussed in this episode Kevin recommends books by Vaclav Smil, including his works on energy Kevin also recommend reading Loonshots MIT on Quaise's holes Bloomberg on Quaise's gameplan Quaise's latest (2022) financing round of $52 million More about Kevin Bonebrake Kevin Bonebrake is the CFO of Quaise Energy. He joined the startup from Lazard, where he was a Managing Director in the financial advisory business focused on the energy industry. Prior to joining Lazard in 2017, Bonebrake was a Managing Director in Morgan Stanley's Global Natural Resources investment banking practice and was a Vice President with Citigroup's Global Energy, Power and Chemicals investment banking team. Bonebrake completed his graduate research in industrial laser applications in the Naval Architecture department at the Helsinki University of Technology and was a member of the intellectual property licensing team at Delphi Automotive.

Host: Ben Banerjee & Sveta Banerjee Topic: Tackling Food Insecurity Guest: Eero Pisilä MD Perunamestarit Oy, MD Tanzanice Agrofoods Ltd, Chairman Luonnosta Finland Ltd. Eero Pisilä - Enterpreneur and founder of Perunamestarit Oy since 1987. Company has built on 90's seedpotato production and marketing model from finnish farms to global market, volumes over 10milj kg of certified seedpotatoes before business was sold to Dutch company HZPC. - Chairman of Luonnosta trading company since 2005, building efficient international trading model for potatoes, fruits and vegetables. Network to over 20 countries. - Founder and MD of Tanzanice Agrofoods Ltd since 2017. - Investor and chairman of Pohjolan Peruna Oy, Finland biggest potato processing factory 2007- 2021,when shares were sold. - Chairman of Seed Traders association of Finland on 2000's. - Studies of Agrotechnology 1974-1978 in Helsinki University. - Potato farm enterpreneur in Finland 1976 - 2014.

Pastor Carolyn Hetrick of Grace Lutheran Church, State College, PA is joined by Dr. Kirsi I. Stjerna, the First Lutheran, Los Angeles/Southwest California Synod Professor of Lutheran History and Theology at California Lutheran University, Pacific Lutheran Theological Seminary; Core Doctoral Faculty, Graduate Theological Union, Berkeley; Docent, Helsinki University, Finland. Today we talk about Galatians 5:22-23, peace, compassion and freedom theology. Today's music is "Be Thou My Vision." This is a soulful arrangement of the beloved traditional hymn Be Thou My Vision, composed by Judy Nishimura, and recorded by Laurel Sanders, flutist, with permission of ALRY Publications. The score is available at www.alrypublications.com.A native of Finland, Kirsi is a Lutheran theologian engaged in critical and compassionate examination of the relevance of Luther's freedom theology for the contemporary world. She has broad interests in the Reformation scholarship and with the sources in Christian theology. Her book Women and the Reformation (Wiley 2008) broke new ground by bringing women's theological voices to the conversation. In her Luther scholarship, she has focused on theology of faith and sacraments, and critical uprooting of antisemitism in Christian argumentation. The Annotated Luther, Vol. I-VI (Fortress, 2015-2017) was a major undertaking that saw its completion in the Reformation anniversary year. In 2021 she published Lutheran Theology: A Grammar of Faith (Bloomsbury/T&T Clark) for classroom use. 

Axial spondyloarthritis is a chronic progressive inflammatory arthropathy, which ultimately may lead to radiographical changes in the spine and sacroiliac joints. This radiographical stage is known as ankylosing spondylitis. Inflammatory back pain is the hallmark clinical feature. This is defined as back pain that is of insidious onset, is worse in the morning, and improves with exercise. In this podcast, Markku Kauppi, Professor of Rheumatology, Helsinki University, gives a clinical overview of the condition. For more on ankylosing spondylitis, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/366 - The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner's judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

The 1939 Winter War is Finland's creation story. It's a war that Finland fought virtually alone, relying only on its own weapons and resources, against the might of the Soviet Union. It's a war that the USSR failed to win. And it's a war that Stalin believed he would win within 12 days! After 700 years of being an integral part of the Swedish Empire, Finland was taken by Russia in 1808 and eventually annexed. After the Russian Empire ceased to exist in 1917, Finland declared its independence and then fought a bloody and brutal civil war against its own Bolsheviks. Unlike many former lands and nations of the Russian Empire, such as Ukraine, Finland managed to keep its independence. But as the power of the Third Reich increased in Europe, the Soviets attacked Finland. And despite their inability to win against a smaller and weaker Finnish force, the Russians did gain what they were looking for. Hint: Finland lost territory to USSR. Since Finland has suddenly ended its decades-long policy of appeasing Russia by applying for NATO membership, we decided to examine Finland's recent history to better understand not only its similarities but also its differences with Ukraine's history and challenges. To dig deep into Finland's history, we spoke with Dr. Jason Lavery who joined us from Helsinki for this conversation. He is a permanent adjunct professor at Helsinki University, and also a professor at Oklahoma State University's Dept. of History. To learn more about Dr. Lavery, his many projects and publications, visit his academic homepage and also personal website. I hope you enjoy this episode. Adel Host of ThePeel.news podcast S2E20: Why We Wage War? S2E8: History of Ukraine's Wars S2E19: Poland and Ukraine SUPPORT: please click here and join our other supporters in the news peeler community. Thank you.

Evelina Kurgonaitė-Swoboda is the Secretary General at the Fair Standards Alliance – a Brussels-based association that advocates fairer licensing of standardised technology in the development and rollout of the IoT. Evelina previously served as Head of Policy Strategy and Legal Counsel at Samsung Electronics in Brussels. Evelina has 15+ years of experience in EU & competition law and public affairs. Having spent seven years in private practice – including at Sidley Austin and Morrison Foerster – Evelina established and managed the European arm of global news service PaRR, part of the Financial Times group at the time. Evelina holds LL.M from Helsinki University and MA from King‘s College London. Evelina is the founder and chair of Women AT (W@) – a platform that connects and promotes women professionals around the world.In the podcast, Evelina elaborates on the view of the Fair Standards Alliance on matter such as the regulation of public authorities on FRAND matters, transparency about claim charts, transparency about comparable license agreements and the problem of extensive NDA provisions. She also explains why in her view Avanci is not always seen as the neutral platform representing both licensors and licensees and Evelina presents her view about how SEP licensing may work for new IoT applications.

Selamat datang kembali di Nona Chats - seri di mana kita berbicara dengan orang-orang yang sangat inspiratif dari berbagai bidang. Di sini kita berbicara tentang segalanya, termasuk kehidupan pribadi mereka, perjalanan karir mereka, healthy habits mereka, dan tentu saja cerita menstruasi mereka. --- Nona Chats with Dr. Ferry: Untuk episode ini, kami berbicara dengan Dr. Ferry Darmawan. Dr. Ferry meraih gelar spesialisnya dari Universitas Indonesia, Jakarta. Ia merampungkan Program Pertukaran Profesional IFMSA di Helsinki University, Finlandia. Dr. Ferry mengikuti pelatihan Minimal Invasive Gynecological Surgery (MIGS) di the European Academy or Gynecological Surgery di Thessaloniki, Yunani. Selain itu, ia mengasah kemampuan profesionalnya di bidang endoskopi di the International Society of Gynecological Endoscopy. Sertifikat pelatihan juga diperoleh Dr. Ferry di bidang IGES Laparoscopic Surgery (Bedah Laparoskopi IGES) dari RSPAD Gatot Soebroto, Jakarta, Indonesia. Ia merupakan anggota the Indonesian Gynecological Endoscopy Society dan Perkumpulan Obstetri dan Ginekologi Indonesia. Saat ini dr. Ferry SpOG memiliki jadwal praktik di RSPAD Gatot Soebroto, Bocah Indonesia dan Rumah Sakit Tzu Chi-Pantai Indah Kapuk. Dengarkan kami mengobrol tentang fertilitas, empat tanda tanda menstruasi tidak normal dan harus ke OBGYN, pola makan dan jumlah olahraga terbaik untuk jaga kesehatan hormon, penyebab gangguan ovulasi, cara mengatasi endometriosis… Follow Dr. Ferry di @dr.ferryd --- Nona Woman: Website: www.nonawoman.com Instagram: @nonawoman Youtube: Nona Woman Nona Woman Mobile App: Apple App Store: Download Free Google Play Store: Download Free

WATCH: https://youtu.be/NbGkWjyyLKc Risto Miikkulainen is a Professor of Computer Science at the University of Texas at Austin and AVP of Evolutionary Intelligence at Cognizant AI Labs. He received an M.S. in Engineering from the Helsinki University of Technology (now Aalto University) in 1986, and a Ph.D. in Computer Science from UCLA in 1990. His current research focuses on methods and applications of neuroevolution, evolutionary computation, machine learning, cognitive science as well as neural network models of natural language processing and vision; he is an author of over 450 articles in these research areas. In 2016, he was named Fellow of the Institute of Electrical and Electronics Engineers (IEEE) for contributions to techniques and applications for neural and evolutionary computation. EPISODE LINKS: - Risto's Website https://www.cs.utexas.edu/users/risto/ - Risto's Publications: https://scholar.google.com/citations?user=2SmbjHAAAAAJ&hl=en CONNECT: - Website: https://tevinnaidu.com/podcast - Instagram: https://instagram.com/drtevinnaidu - Facebook: https://facebook.com/drtevinnaidu - Twitter: https://twitter.com/drtevinnaidu - LinkedIn: https://linkedin.com/in/drtevinnaidu TIMESTAMPS: (0:00) - Introduction (1:13) - Evolution of Future Minds (4:37) - Sci-fi Influences (6:29) - Computational Models in Medicine (12:04) - AI & Human Minds (16:45) - Consciousness Models (20:53) - Similarities Between Biology & Computers (24:25) - Computing Human Behaviour (32:18) - Computer Algorithms vs Human Psychology (39:43) - Human Augmentation (Superhuman) (45:11) - Neuroevolution & Evolutionary Computation (1:00:15) - Cognizant AI Labs (1:03:18) - Ethical Dilemmas in AI (1:11:25) - Risto's AI Vision For The Future (1:15:41) - Conclusion Website · YouTube · YouTube

WATCH: https://youtu.be/NbGkWjyyLKc Risto Miikkulainen is a Professor of Computer Science at the University of Texas at Austin and AVP of Evolutionary Intelligence at Cognizant AI Labs. He received an M.S. in Engineering from the Helsinki University of Technology (now Aalto University) in 1986, and a Ph.D. in Computer Science from UCLA in 1990. His current research focuses on methods and applications of neuroevolution, evolutionary computation, machine learning, cognitive science as well as neural network models of natural language processing and vision; he is an author of over 450 articles in these research areas. In 2016, he was named Fellow of the Institute of Electrical and Electronics Engineers (IEEE) for contributions to techniques and applications for neural and evolutionary computation. EPISODE LINKS: - Risto's Website https://www.cs.utexas.edu/users/risto/ - Risto's Publications: https://scholar.google.com/citations?user=2SmbjHAAAAAJ&hl=en CONNECT: - Website: https://tevinnaidu.com/podcast - Instagram: https://instagram.com/drtevinnaidu - Facebook: https://facebook.com/drtevinnaidu - Twitter: https://twitter.com/drtevinnaidu - LinkedIn: https://linkedin.com/in/drtevinnaidu TIMESTAMPS: (0:00) - Introduction (1:13) - Evolution of Future Minds (4:37) - Sci-fi Influences (6:29) - Computational Models in Medicine (12:04) - AI & Human Minds (16:45) - Consciousness Models (20:53) - Similarities Between Biology & Computers (24:25) - Computing Human Behaviour (32:18) - Computer Algorithms vs Human Psychology (39:43) - Human Augmentation (Superhuman) (45:11) - Neuroevolution & Evolutionary Computation (1:00:15) - Cognizant AI Labs (1:03:18) - Ethical Dilemmas in AI (1:11:25) - Risto's AI Vision For The Future (1:15:41) - Conclusion Website · YouTube

We're excited to have, from all the way in Switzerland, Tanja Dowe the CEO of Debiopharm Innovation Fund on the show. Tanja has a background in microbiology and biochemistry and is an expert in business models and market requirements for life science companies. We're going to learn from her experience in acquisitions, investments, and commercialization of life science companies across Europe and some recent investments in the US. About DebiopharmDebiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.About Tanja DoweMrs. Dowe graduated from the Helsinki University of Technology (now Aalto University) where she obtained an MSc in Microbiology & Biochemistry in 2000. Tanja has always been interested in diagnostic and smart data solutions for precisions medicines. She has held several managing positions and has 18 years of experience in building business strategies, analyzing markets, in-/out-licensing and business acquisitions with more than 80 life sciences companies. She has strong knowledge in business models and market requirements necessary to commercialize innovations in the life science markets. Prior working at Debiopharm, Tanja was the Managing Partner of Innomedica Ltd, a leading European strategy consulting company in life sciences. She joined Debiopharm Innovation Fund S.A. in 2016.Resource links: debiopharm.comTanja's LinkedInDebiopharm's investment in VeriSIMVeriSIM Life websiteQualioApply to be on the show: https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldez

Wen Chen, a food scientist.  The path to practice as a professional food scientist took 12 years from China to Finland.  After the Master degree in Food sciences in Helsinki University, her will to go back home became diminished.  She decided to continue her academy career in the PhD study in Phsical Chemistry.  After the study, she was unemployed.  Luckily her will to stay continued with the postdoc place in the familiar campus in Chemistry.  When the project ended, instead of getting unemployed she opened a Cafe in Kallio, Helsinki.  Then the corona came, the business went down.  This time an angel stays with her.  A friend of hers came with a hope to work in a start-up food company.  When people got lucked down at home, she went to her familiar environment - the laboratory.  Her perspectives to foods open from the chinese tradition to the finnish contemporary innovations to food materials.  Let's travel together with Wen Chen's food world beyond time and space.

“Song of the Reed”, a documentary film about four taiwanese women's life stories, who suffered military sexual slavery for Japanese soldiers during World War Two, how they overcame physical and mental trauma and grew in their attitudes toward life through 16 years of Physical and Mental Health Workshops.  In this film, the director Hsiu-Chng Wu manifests the history of the ‘Comfort Women' issue and its social impacts through the grandmom-aged taiwanese women's daily activities at home and with their families, in the therapies and in the groups. To reflect from our today's world, the organizer and facilitator Professor Julie Chen from the East Asian studies of Helsinki University wants to raise the awareness of women's rights, particularly those who are suffering systematic violence against their will.  As Professor Chen comments in the interview: ‘The whole lesson we learnt is that we need to believe that there are people willing to accept us and to listen to us even when you have faced such a challenge in your life.  In most developed countries, there are NGOs willing to work with you and to walk out from your trauma.  So we need to willing to seek helps and we need to willing to talk about it.  In fact, when you stand out to talk about it, also encourage other victims to stand out and to document the injustice that has been happened in history.'The Film Screening and the dialogue with film director: Friday, 5th of November, 12.00-14.00 Helsinki time (Register before 1st of November, 2021 via https://elomake.helsinki.fi/lomakkeet/113384/lomakkeet.html )Info & registration for the film screening Song of the Reed and dialogue with film director Hsiu-Ching Wu:https://blogs.helsinki.fi/spotlighttaiwan/film-screening/https://www.facebook.com/helsinkichinastudieshttps://twitter.com/julieyuwenchen?lang=en

Hannes Heikenheimo co-founded Speechly in 2016 with the vision to create a low-latency, real-time streaming speech recognition API. Today, Speechly offers an API that it says is the fastest voice UI for the web and other platforms. Prior to Speechly, he was a data science partner at Reaktor, a language engineer working on Siri for Apple, the analytics lead at game-maker Rovio, a Senior Data Scientist at Nokia, and a machine learning researcher at Helsinki University of Technology where he earned his PhD.

Join us in The BreakLine Arena for an engaging conversation with Sami Inkinen, Chief Executive Officer and Co-Founder of Virta Health.In this episode Sami provides deeper insight into how his Finnish upbringing shaped his incredible work ethic and ultimately provided him the courage to become a tremendously successful data-driven technology entrepreneur.A data-driven technology entrepreneur, Sami's personal connection to diabetes and passion to advance health on a global scale was the motivation behind Virta Health and its innovative approach to diabetes care.Virta Health provides the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery.Previously, Inkinen was the co-founder of the leading online real estate marketplace Trulia, serving as its COO and president and board member until its IPO and eventual sale to Zillow Group. He also worked on Microsoft's strategy team for MS Office, and as a consultant for McKinsey & Company within the software, telecommunications, and government sectors.As a venture partner at Obvious Ventures, Inkinen also invests in and advises healthcare IT companies.To raise awareness about the dangers of sugar and its connection to diabetes, Sami started Fat Chance Row. During the summer of 2014, Sami and his wife rowed from California to Hawaii—2,750 miles, completely unsupported. He is also a triathlon age group world champion and 8 hour 24 minute Ironman with seven Hawaii Ironman finishes.A physicist by training, Sami started his career as a radiochemist at a nuclear power plant and holds a Master of Science in engineering physics from the Helsinki University of Technology. He also earned a Master of Business Administration from Stanford University. He thinks his greatest luxury today is a small vegetable garden at his San Francisco Bay area home, where he lives with his wife and two daughters.If you like what you've heard please like, subscribe, or rate The BreakLine Arena on your preferred streaming platform! We would also love to hear your thoughts, feedback, or recommendations on the content we are creating. Feel free to reach out to us at questions@break-line.com.To learn more about BreakLine Education visit us at breakline.org.

Jussi Åkerberg is Chief Technology Operator of AW-Energy, the world leading wave energy technology developer. He has a strong industrial background with over 20 years of experience in demanding multidisciplinary technology development and a Master's of Science in Electrical Engineering, from Helsinki University of Technology in Finland. In today's episode, some of the things we talked about were: what the Finish culture is like, what is wave energy technology, why is it so important, what the future of renewable energy will look like, and much more! Dangerously Good with Jay Sikand is a long-form podcast where Jay explores dangerously good topics and ideas! This show is about learning new things and sharing that journey with the world! Expanding the minds and imaginations of those who want to partake. Expect new episodes and clips every Tuesday! Watch the podcast on the Dangerously Good YouTube channel (https://www.youtube.com/watch?v=p3bGjggJTQY) & For CLIPS of the podcast, subscribe to the Dangerously Good Clips Youtube channel! (https://www.youtube.com/channel/UChmDAQzfpNdmEi10lqBReuQ) Chapters: 0:00 - Intro 1:02 - What's the culture like in Finland? 14:08 - How Jussi became a Chief Technology Officer 32:52 - Wave energy and how to harness it 41:46 - Criteria of success for wave energy capture 43:55 - How does wave energy capture compare to solar & wind capture? 55:25 - How is wave energy stored? 1:00:38 - Wave-roller Technology, wave energy capture device 1:06:43 - Funding a capital-intensive project 1:10:36 - Drawbacks of this technology 1:16:54 - How was the Wave-roller Technology was engineered and managed 1:24:24 - What will the future of renewable energy look like? 1:27:02 - Opinions on Elon Musk 1:42:24 - What is Jussi most grateful for? About Jay Sikand: He is a podcaster, actor, tech nerd, and lover of life that explores ideas from entertainment, technology, philosophy, politics, health, fitness to whatever else is intriguing. He has conversations with friends and people of strong morals, ambitions, and intelligence within their fields. Anyone who wants to journey through enlightening conversions that contain dangerously good information should tune in! --- Support this podcast: https://podcasters.spotify.com/pod/show/jay-sikand/support

La inteligencia artificial no es solo cosa del futuro, sino del presente. De hecho, los verdaderos expertos suelen tener suficiente con hablar de lo que está ocurriendo ahora en el campo y las especulaciones acaban cayendo en manos de aficionados que no tienen realmente una perspectiva completa del estado del arte. En este programa hemos querido abordar el futuro de la inteligencia artificial contando con dos expertos, Darío Gil y Carlos Santana.Darío Gil es doctor en Ingeniería Eléctrica e Informática por el MIT. Actualmente es director de investigación de IBM, uno de los laboratorios de investigación corporativos más grandes e influyentes del mundo. Su cometido es liderar la hoja de ruta tecnológica de IBM, dirigiendo las estrategias de innovación en áreas que van desde la computación cuántica a la Inteligencia Artificial. Asimismo, Darío copreside el Laboratorio de Inteligencia Artificial MIT-IBM Watson y copreside el consorcio de Computación de Alto Rendimiento COVID-19, el cual brinda acceso a los recursos informáticos de alto rendimiento más poderosos del mundo en apoyo de la investigación de esta pandemia. Del mismo modo, Darío también es miembro de la Junta Nacional de Ciencias, el órgano rector de la Fundación Nacional de Ciencias, miembro de la Junta de Gobernadores de la Academia de Ciencias de Nueva York y fideicomisario del Salón de la Ciencia de Nueva York.Carlos Santana Vega es un divulgador, youtuber y profesor en el campo de la Inteligencia Artificial y el Machine Learning. Estudió Ingeniería Informática (y ADE) en la ULPGC, y se especializó en el área de análisis de datos con un MSc en Data Science por la Helsinki University. Es el creador del canal de YouTube DotCSV que cuenta con más de 450,000 suscriptores donde pone el foco en el desarrollo actual del campo de la IA. También es profesor de la Escuela de Organización Industrial, participando como docente en diversos cursos y masters de Machine Learning & Data Science, así como en formaciones para empresas.

Hot topics in current academic research on the Nordic region today include welfare, colonialism and heterogeneity. These – as well as a host of other issues - form the content of this podcast, the last in the series ‘The Nordics Uncovered: Critical Voices from the Region'. Editor of nordics.info, Nicola Witcombe, is joined by Mary Hilson Professor of History at Aarhus University in Denmark and  Peter Stadius Research Director at the Centre for Nordic Studies at Helsinki University. Their conversation also takes in: Traditional histories versus new perspectives.A Europe of Regions e.g. the Oresund.The rise of nationalism.Finnish colonialism.Find out more on nordics.info.Sound credits from freesound.org including "Noir" Reel by Hainbach by makenoisemusic, loneliness by rashta and The Plan - Upbeat Loop by ispeakwaves.

Marco Casagrande, Finland, Shenzhen Marco Casagrande (born 1971) graduated from the Helsinki University of Technology Department of Architecture in 2001. From the early stages of his career Casagrande started to mix architecture with other disciplines of art and science landing with a series of ecologically conscious architectural installations around the world. All in all, more than 86 realized works in 16 countries. He is the laureate of the European Prize for Architecture 2013, Committee of International Architecture Critics CICA Award 2013 for conceptual and artistic architecture and UNESCO & Locus Foundation's Global Award for Sustainable Architecture 2015. Casagrande's works and teaching are moving freely in-between architecture, landscape architecture, urban and environmental design and science, environmental art and circus adding up into cross-over architectural thinking of «commedia dell'architettura», a broad vision of built human environment tied into social drama and environmental awareness. «There is no other reality than nature». He views architects as design shamans merely interpreting what the bigger nature of the shared mind is transmitting. He views cities as complex energy organisms in which different overlapping layers of energy flows are determining the actions of the citizens as well as the development of the city. By mixing environmentalism and urban design Casagrande is developing methods of punctual manipulation of the urban energy flows in order to create an ecologically sustainable urban development towards the so-called Third Generation City. The theory views the future urban development as the ruin of the industrial city, an organic machine ruined by nature including human nature. Urban Acupuncture: a cross-over architectural manipulation of the collective sensuous intellect of a city. The City is viewed as a multi-dimensional sensitive energy-organism, a living environment. Urban acupuncture aims into a touch with this nature. UA: Sensitivity to understand the energy flows of the collective chi beneath the visual city and reacting on the hot spots of this chi. Architecture as environmental art is in the position to produce the acupuncture needles for the urban chi. A weed will root into the smallest crack in the asphalt and eventually break the city. Urban acupuncture is the weed, and the acupuncture point is the crack. The possibility of the impact is total, connecting human nature as part of nature. The theory opens the door for uncontrolled creativity and freedom. Ruin is something man-made having become part of nature. Casagrande has been teaching in 65 academic institutions in 25 countries since the year 2000 including the Aalto University, Helsinki University of Art and Design, Tokyo University Tadao Ando Laboratory and China Central Academy of Fine Arts. He was a visiting professor at the Bergen School of Architecture 2001–2004 and Taiwanese Tamkang University Department of Architecture 2004-2009, Principal of the independent cross-disciplinary research centre Ruin Academy in Taipei and Taitung, Taiwan (2010 -) and Artena, Italy (2013 -) in cooperation with the Aalto University's SGT Sustainable Global Technologies Centre. Casagrande is the Vice-President of the International Society of Biourbanism (2014 -). Currently he holds the professorship of architecture at the Bergen School of Architecture, Norway. Marco Casagrande is the Principal of the Casagrande Laboratory (2003-), a Finland based internationally operating multi-disciplinary architecture and innovation office. Ultra-Ruin by Marco Casagrande Marco Casagrande, Ultra-Ruin Bug Dome by WEAK! in Shenzhen  

He - a candidate of Green party, a writer, a graduated PhD in social sciences. 24 years ago, he was on the crossing road to choose his career path. Like most of Bangladeshi master degree graduated, he could find a descent and prestigious job in civil services. Instead he went back to Dhaka University library. This time, he aimed at the information for a higher education and found an exotic name - Finland. In year 1996, he was accepted as an international student for a Doctor degree of Social Sciences in Helsinki University. Mojibur Doftori’s path in Finland is prominent with his academic aspiration. He worked as a researcher in University of Helsinki and Tampere in Finland and Roskilde in Denmark, as a trustee and chair in PEN (Peer Educators Network) and as a project officer in Peace Union of Finland. After work contracts ended, he unemployed and started to write a book ‘Career Development’. Year 2020 he was on a book promotion tour to his homeland Bangladesh. The numerous lectures and discussions inspired him. He realized that he has the capacity to give his knowledge and skills to help the people. After the trip, he decided to give it a try. Today he wants to use Green party as a platform and to speak for the immigrants in Helsinki. He aims to work for youth empowerment, integration of immigrants and inclusive of all in Finnish society. Equality for all is his vision. Dr. Mojibur Doftori’s websites: https://mojiburdoftori.com & Facebook: @authormojibur

If you have listened to Hunger Hunt Feast for any amount of time you are already aware of the health issues and dangers around soy and soy products.  In today's episode, Zane takes a further look into the soy conversation as it regards to women, estrogen, and even pregnancy. QUICK NOTES FROM ZANE: Isoflavones are know to cause infertility in livestock, birds, pets and humans. Soy is the only plant in our food system that has a significant amount of isoflavones. Effect of soy on fertility Effect of soy on menstrual cycle No benefit of soy in treating symptoms of menopause Soy causes thickening of the lining of the uterus Soy reduces sperm count in humans and animals Worldwide, sperm counts dropped during the 20th century Soy lowers testosterone and sperm count Soy causes lower testosterone, breast enlargement and nipple discharge in men Soy isoflavones can cross the placenta and affect the development unborn children   LINKS: The Whole Soy Story" by Kaayla Daniel https://www.amazon.com/Whole-Soy-Story-Americas-Favorite/dp/0967089751 Dietary Estrogens- A Probable Cause of Infertility and Liver Disease in Captive Cheetahs: https://www.gastrojournal.org/article/0016-5085(87)91006-7/pdf 19 Soya--a dietary source of the non-steroidal oestrogen equol in man and animals https://joe.bioscientifica.com/view/journals/joe/102/1/joe_102_1_008.xml Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women https://academic.oup.com/ajcn/article-abstract/60/3/333/4731888?redirectedFrom=PDF Five Studies Showing No Relief Of The Symptoms Of Menopause With Soy Supplementation, Monash University in Australia https://www.tandfonline.com/doi/abs/10.1080/13697130008500108?journalCode=icmt20 Dept of Food Science and Human Nutrition at Iowa State https://journals.lww.com/menopausejournal/Abstract/2001/05000/Phytoestrogens_and_healthy_aging__gaps_in.4.aspx University of Milan https://www.researchgate.net/publication/10766649_Effect_of_soy-derived_isoflavones_on_hot_flushes_endometrial_thickness_and_the_pulsatility_index_of_the_uterine_and_cerebral_arteries University of Pittsburg https://pubmed.ncbi.nlm.nih.gov/12113884/ Helsinki University https://pubmed.ncbi.nlm.nih.gov/12798527/ Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study https://pubmed.ncbi.nlm.nih.gov/15237003/ The oestrogenicity of equol in sheep https://pubmed.ncbi.nlm.nih.gov/6502066/ Male reproductive toxicology: comparison of the human to animal models https://pubmed.ncbi.nlm.nih.gov/3289906/ Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? https://pubmed.ncbi.nlm.nih.gov/8098802/ First direct evidence that environmental oestrogens affect sperm fertility https://www.eurekalert.org/pub_releases/2002-07/esfh-fde063002.php inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men https://europepmc.org/article/med/10798211 Effects of replacing meat with soyabean in the diet on sex hormone concentrations in healthy adult males https://www.cambridge.org/core/services/aop-cambridge-core/content/view/50C464775151BA6ECBF767221F763AFF/S0007114500001872a.pdf/div-class-title-effects-of-replacing-meat-with-soyabean-in-the-diet-on-sex-hormone-concentrations-in-healthy-adult-males-div.pdf “Moobs” Man Boobs And Soy https://www.westonaprice.org/health-topics/soy-alert/moobs-man-boobs-and-soy-2/ Detection of phytoestrogens in samples of second trimester human amniotic fluid https://pubmed.ncbi.nlm.nih.gov/11888703/ Midgestation Intrauterine Exposure of the Human Fetus to Dietary Isoflavones In North America: How Does This Exposure Compare with Animal Studies in Late Gestation and Lactation That Alter Developmental Endpoints? Claude Hughes https://academic.oup.com/jn/article/130/3/666S/4686190#164168804 Tragedy and Hype: Third International Soy Symposium https://www.westonaprice.org/health-topics/soy-alert/tragedy-and-hype-third-international-soy-symposium/ Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia https://pubmed.ncbi.nlm.nih.gov/9524579/ Developmental estrogenization and prostatic neoplasia https://pubmed.ncbi.nlm.nih.gov/7508622/   Questions? You can email your questions to zane@zanegriggs.com. Connect with me at zanegriggs.com or on Instagram @zanegriggsfitness   QUICK EPISODE SUMMARY The estrogen effect of soy What do the studies say vs the market narrative? Natural vs soy supplemented diet in pertaining to animals The impact of soy on fertility in women The impact of soy on fertility in men How soy decreases testosterone in men Dietary soy in pregnant women The risk to benefit ratio of having soy in your diet Ditch the soy

In Episode 8 of Series 3 of the DIAL Podcast, Katri Räikkönen from Helsinki University and a member of DIAL’s PremLife project, talks about her research investigating whether the babies of mothers who whilst pregnant are prescribed steroid drugs, because of concerns around premature births, are more likely to develop behavioural and mental disorders later on. Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioural Disorders in Children is research published in the Journal of the American Medical Association. 

In this episode, we meet Sami Inkinen, Co-Founder and CEO of Virta Health. Virta is an online specialty medical clinic that helps people reverse type 2 diabetes & other chronic conditions safely and sustainably, without the risks, costs, or side effects of medications or surgery. Virta's innovations in nutritional biochemistry, data science and digital tools combined with their clinical expertise are shifting the diabetes treatment paradigm from management to reversal. Virta has experienced a growth rate of nearly 200% year over year, and now works with over 100 of the largest health plans, employers, and government organizations and treats patients in all 50 states. Virta recently announced a $133M Series E round, led by Tiger Global. The Series E financing follows a recent $65 million raise in December of 2020, nearly doubling the company's valuation in just 5 months to $2 billion. Previously, Sami was the co-founder of the leading online real estate marketplace Trulia, serving as its COO and president and board member until its IPO and eventual sale to Zillow Group. He also worked on Microsoft's strategy team for MS Office, and as a consultant for McKinsey & Company within the software, telecommunications, and government sectors. As a venture partner at Obvious Ventures, Inkinen also invests in and advises healthcare IT companies. Sami holds a Master of Science in engineering physics from the Helsinki University of Technology and a MBA from Stanford University. In this episode, Sami and I chat about: How Sami's personal connection to diabetes and passion to advance health on a global scale led to the founding of Virta Health Why there has been no improvement in population-level outcomes for diabetes patients despite trillions of dollars spent over the past decade Virta's approach to reversing type 2 diabetes and other metabolic diseases, leading to gross savings of $5,000/patient per year and sustained improvements in patient outcomes The required shift in telemedicine from episodic care to continuous care in order to achieve outcomes that were previously not possible Sami's learnings from his journey as a serial entrepreneur and advice to others hoping to make an impact in the healthcare industry

Mikko Koria; a curious person who wears many hats: about design, interdisciplinarity and ways to reach joint meanings. Mikko Koria is; the Professor in Design Innovation and the Director of the Institute for Design Innovation at Loughborough University London, and Visiting Professor at Aalto University, Finland. He holds degrees in Architecture from University of San Paulo and Helsinki University of Technology, an MBA in Design Management from the University of Westminster and a PhD in Economics and Business Administration from the Helsinki School of Economics.Over the last thirty years, Mikko has led complex, multicultural, and interdisciplinary initiatives and organisations, building teams and meaningful solutions in humanitarian work and business contexts, in many cases linking technical and social goals. Next to SMEs, start-ups, and multinationals, he worked with organizations such as the Red Cross, EU, UNICEF the World Bank in the UK, Finland, Brazil, and multiple other Asian, African, and South American countries. Key areas of research and professional practice include design driven education and training, value-intensive management, service design and innovation, policymaking, business models and ecosystems, entrepreneurship, and global management.Today we are pleased to have Mikko Koria is with us and engage in a reflective chat about design, research, identity, interdisciplinarity and ethics. Mikko introduces himself as a person who has never quite figured it out and is constantly driven by curiosity to understand what is around the corner. From here on, we discuss design innovation and its inherent interdisciplinarity. How does a designer use the co-creation tools differently from an anthropologist? How to give voice to the people who do not understand their input? How to work around different agendas and achieve a joint meaning? At the end, Mikko reflects on the humane qualities that might bring a design practitioner closer to figuring out the unknowns.Mentioned in Podcast: Institute for Design Innovation at Loughborough University London, https://www.lborolondon.ac.uk/institutes/design-innovation/Social media: LinkedIn - https://www.linkedin.com/in/mikko-koria-44864a1/

Dr. Kaarle Hämeri, Chancellor of Helsinki University, holds a role unlike other chancellors around the world: his primary responsibility is specifically advocating for the university and higher education on a national scale. His work includes taking care of the external relationships for the university, and engaging with external constituencies in support of the university. This conversation explores how higher education is viewed by the public in Finland and the Nordic countries; his insights on the public benefit of science, and how to communicate about it; and the importance of respecting your audience and not underestimating them when explaining complex research and discovery. Bonus tip: practice your talks on your family. He shares how his experience on a CASE Study Tour helped him understand advancement. Chancellor Hämeri is a Professor of Physics and has served as Vice Head of the Physics Department and Chair of the Union of University Professors.

Roie Galitz is an award-winning, NYC based, wildlife photographer and entrepreneur. For over a decade, he has been exploring and documenting our planet’s wildlife and nature, from the Arctic to the Antarctic. His intimate and innovative work was presented in local and international exhibitions, featured in exclusive magazines and honored with over 70 international awards, including the prestigious Picture of the Year for reportage of Science and Natural History. With equal passion and commitment, Roie is acting as a Greenpeace ambassador and engaging in conservation work around the globe. His video and still photography is a strong testimony to the struggle of the majestic animals he meets throughout his expedition, under the threats of climate change . To help protect them, he shares their stories in fascinating talks. He is recognized for his talks at the United Nations HQ, the NYC Climate Week and TEDx talks in Helsinki University, Glasgow and Wexford alongside global conventions everywhere. Traipsin’ Global on Wheels is focused on sharing resources and insights into disability advocacy, fitness and health, and accessible travel. Our mission is to build a community of healthy, worldly, and informed advocates. Please send your feedback and stories to: tgowpodcast@gmail.com. You really want to hear from YOU, our listeners! end credit music: "Protest Song" by Derek Clegg.

Carinne Brouillon is a Member of the Board of Managing Directors, with responsibility for the Human Pharma Business Unit Professional milestones 2018 – 2019 Global Head of Therapeutic Areas, Boehringer Ingelheim 2014 – 2018 Head of Global Commercial Strategy Neuroscience at Janssen, Johnson & Johnson’s Pharmaceutical Company 2012 – 2018 President of Janssen Therapeutics and Member of the Janssen North America Leadership Team Edward Hæggström Born 1969. Finnish citizen. Co-founder of Nanoform, CEO and a member of the Management Team since 2015. Education: Ph.D. degree in applied physics from the University of Helsinki and a Master of Business Administration degree in innovation management from Helsinki University of Technology. Experience: Dr. Hæggström has, among others, been a professor at the University of Helsinki and Head of the Electronics Research Laboratory within the Department of Physics. He has previously held the role of visiting professor of physics at Harvard Medical School, visiting scholar (assistant professor) of physics at Stanford University and project leader at the CERN. Rob Scott, MD, a trained physician, has held leadership positions in global pharmaceutical companies for thirty years. During his career he has managed drug development teams responsible for highly successful pharmaceutical brands such as Norvasc, Lipitor, Repatha, Humira, Skyrizi and Rinvoq. Before retiring, his most recent position was Chief Medical Officer and Head of Development at AbbVie where he had oversight on all early and late-stage development programs. He was also responsible for a team of over 4,000 employees spanning 52 countries, a budget of close to $2 billion and programs involving approximately 40 new molecular entities. Before that, he was Vice President, Global Development TA Head and Head of Development Design Center at Amgen where he was responsible for the development of evolocumab (Repatha) the first approved PCSK9 inhibitor, ivabradine (Corlanor), to treat heart failure and omecamtiv mecarbil, a direct myosin activator for heart failure. From 2012 - 2016 he was a member of the US Food and Drug Administration’s Cardiovascular and Renal Drug Advisory Committee where he built strong relationships with senior FDA staff. Before Amgen, he held several leadership positions with emerging pharmaceutical and biotech companies. Dr. Scott is a graduate from the University of Cape Town, South Africa and started his career at Janssen as a Medical Advisor. He is a board member of Transclerate and a member of the PhRMA R&D Leadership Forum.

When “Racism” became taboo, one side the whiteness enjoys a system of racial privilege, while another side constantly pretends with a smile that the wound doesn’t hurt. Alice Jäske, a mixed-race generation, did mind her skin color and decided to open the fact what she has been through during her studenthood. Her pro gradu -study in Faculty of Educational Sciences of Helsinki University “”Am I allowed to identify myself as Finnish?” The white normativity in the Finnish educational system from the point of view of the ones identifying as mixed-race.” (The original title in Finnish: ”Saanko tuntea itseäni suomalaiseksi?” Suomalaisen koulutusjärjestelmän valkonormatiivisuus mixed-race-identifioituvien näkökulmasta) (2020) reveals the racial structural discrimination and the whiteness norm in the Finnish schools. In this interview, we focus on the identity formation in the mixed-race generation and how the school environment influences their cultural identity.

Hannes Heikinheimo is the Co-Founder and CTO of Speechly, a voice AI company that specialises in adding voice capabilities to software products, and he joins us to discuss the benefits and steps you need to follow to do this.Hannes has deep experience in voice technologies, working with the Helsinki University of Technology, Nokia, Rovio and Apple, launching the Finnish Siri.We chat to Hannes about the Speechly technology, the drawbacks of traditional speech to text, the difficultly of language modelling the Finnish language, the advantage of voice-enalbed software, broader voice industry trends and how to add voice to your app.Companies around the world are looking for conversation designers, a rare breed of people to help them advance communication between people and AI. That's where we help!Conversation Design Institute leads in training and certification for Conversation Designers, Conversational Copywriters, and AI Trainers. Our human-centric workflow has proven itself around the world. Our certificates ensure you create winning conversational experiences.As advocates for the Conversation Design profession, we continue to work closely with tech partners, agencies and other key players in the industry. With this support, Conversation Design Institute is well on its way to becoming the number one platform in conversation design.Save 25% with code CDI972VUX25OFFFIND OUT MORELinksSpeechlyConnect with Hannes See acast.com/privacy for privacy and opt-out information.

“How did Japan embrace Western music, how music became part of modern cultural history, and how are the practices and institutions of the music world established in the forms we know today?” These questions are answered in Lasse Lehtonen’s book ‘Japanese Music: From the rumble of taiko drums to J-pop’ (The original Finnish name: ‘Japanilainen musiikki: Taiko-rumpujen kuminasta J-poppiin, 2019). The 519-page literature not only faithfully presents history and modernity, but also Lasse Lehtonen’s passion for Japanese culture and music. This week DongXiNanPei re-broadcasts the two interviews with the author Lasse Lehtonen, the Finnish researcher on Japanese studies at Helsinki University. In this interview, Lasse Lehtonen will introduce the Japanese music from the perspective of multiculturalism and his stories encountering with Japanese music.

Marko Koskinen, 47yo, from Finland is the founder of Phoenix Online School, a K9 elementary homeschooling alternative for students in Finland. During years 2017-2019 Marko was a member of the Council of the European Democratic Education Community (EUDEC) and has been an active member of the Democratic Education community for over two decades. Marko began his revolutionary education career as a student at the Helsinki University by initiating a student movement at the Helsinki University Education department demanding change in the teaching practices. The end result was a formation of a new kind of teacher education line, where the teacher students decide themselves about their curriculum. There are no tests and the evaluation is mostly based on peer evaluation and mentoring. Marko has worked as a teacher in pre-primary, primary, secondary and adult education for 15 years. His experience has led him to affirm the many critiques towards the education system he already had when he moved from ITC to education field in his early twenties. The main critiques include age segregation, hierarchical governing system, evaluation systems based on rewards and punishments, pre-designed curriculum and the focus on academics instead of well-being. In 2001 Marko participated in an internship program at a private K12 democratic alternative school, Sudbury Valley School, in MA, USA. This experience helped him start his own school in Finland in 2005. The Phoenix School was operational for three years. After the school closed down, during years 2009-2010 Marko travelled for four months in India and studied some Indian philosophers like Sri Aurobindo and Krishnamurti. In 2010 Marko started working on the online school. As an ICT professional he was able to combine Information Technology with education and in 2011 the Phoenix Online School was officially released. The aim of the online school was to allow easy access to homeschooling. During his years as a teacher in public education sector, Marko had seen in practice the many problems of the education system. Even though the Finnish education system is considered to be one of the best in the world, it still has most of the same structures as other education systems and suffers the same problems stated above. With the online school Marko wanted to create a system that would put the student in the center of his/her own studies and give the student and the family as much freedom as possible while still fulfilling the mandatory national curriculum. The solution was to abolish all study content and give the student only questions and tasks. The student was free to decide how to study, when to study, with whom to study and due to the flexibility of the system, also in a great degree, what to study. The Phoenix Online School has been now running for ten years and at the moment has about 90 students, which is about 20% of the homeschoolers in Finland. The online platform has also been successfully tested in regular classroom settings inside Finnish and Spanish public schools. --- Send in a voice message: https://anchor.fm/future-school-leaders/message

This week we are talking to Jasna Žmak (Department of Dramaturgy, Academy of Dramatic Art, University of Zagreb, Croatia). In addition to her academic work that spans across disciplines such as performance studies and gender studies, Žmak is also a creative artist, novelist, scriptwriter, screenwriter and dramaturg. We talk about what her work looks like these days, how she uses her training in the humanities to create art and what keeps her striving to achieve more. Below you'll find a selection of her recent publications. You can follow her on Twitter and Instagram @jasnazmak.As always you can keep to date with on Twitter at @nextgenhum PUBLICATIONS – BOOKS2020 Those Things – Essays on Female Sexuality (One stvari – eseji o ženskoj seksualnosti), Fraktura, Zagreb2019 Lecture as Performance, Performance as Lecture – on the Production of Knowledge in the Arts (Predavanje kao izvedba, izvedba kao predavanje – o proizvodnji znanja u umjetnosti), Leykam International, ZagrebPUBLICATIONS – BOOK ARTICLES2016 Dramaturgy, what a Queer Thing to Do!, The Practice of Dramaturgy: Working on Actions in Performance, ed. Konstantina Georgelou, Efrosini Protopapa & Danae Theodoridou, Amsterdam: Valiz, pp. 149-1562016 Continuous Invisibility, Cultural Ties in the Balkans, ed. Davor Mišković, Rijeka: Drugo More, pp. 63-70 (with Vedrana Klepica)2015 Performing Lectures, Practising Composition: Making Practice. Texts, Dialogues and Documents 2011−2013, ed. Kirsi Monni & Ric Allsopp, Helsinki: University of the Arts, pp. 264-275 (with Konstantina Georgelou)2012 High Hopes, Performing Politics, Politisch Kunst machen nach dem 20. Jahrhundert, ed. Nikolaus Müller-Schöll, André Schallenberg & Mayte Zimmermann, Hamburg: Theater der Zeit (with Reinhard Strobl)https://www.zacharymazur.com/

A panel of international student ambassadors answer your questions regarding studies in Finland!  This is packed with information and lots of great insights. Don't miss you! A big thank you to our student ambassadors from:  ➡️University of Helsinki ➡️University of Turku ➡️University of Jyväskylä (Other universities were invited to participate but unfortunately did not respond). Please see timestamps of the different topics discussed: ⭐Application process 03:35 ⭐Financial Support During Studies 21:48 ⭐University Life/Studies 36:22 ⭐Matter Related to Outside of Uni 52:04 ⭐Social Life 57:01 ⭐COVID Update 01:10:31 ⭐Best Thing About Each University 01:14:07 ⭐University of Jyväskylä 01:14:14 ⭐University of Helsinki 01:15:49, 01:16:42, 01:18:09; ⭐University of Turku 01:17:26 ⭐Advice/Tips for international students 01:19:06. Enjoy! LINKS MENTIONED: https://www.bachelorsportal.com/, https://www.mastersportal.com/, https://www.studyinfinland.fi/admissions?fbclid=IwAR1NA5Lws7R3qXgDPT9i37_cKKdIg1Rfx3Unk-_1lNnCOy0bBBfsZtubQ30

Professor Christopher Vertullo is a specialist orthopaedic knee surgeon. He is the current President of the Australian Knee Society, Chair of the AOA Youth Sport Injury Prevention Working Group and an Adjunct Professor at Griffith University. He is currently listed amongst the top 100 orthopedic influencers in the world.Professor Teppo Järvinen, an orthopaedic surgeon at the department of orthopaedics and trauma at Helsinki University and Helsinki University Central Hospital. Teppo led the Fidelity trial and has a strong interest in the “too much medicine” movement.On this episode we discuss: what is a knee arthroscopy, the evidence for knee arthroscopy in osteoarthritis and meniscal tears and much moreResourcesArthritis Australia - surgery for arthritis See acast.com/privacy for privacy and opt-out information.

Rowan Sanderson sits down with Dr. Anna Hielm-Björkman, leader of the DogRisk research group, and the head of raw research at Helsinki University. Dr. Anna discusses her recently-released paper disproving the link between people getting ill and feeding pets raw food, which was written with the help of 17,000 respondents from 81 countries. The questionnaire was targeted to pet owners who, to some extent, fed raw to either cats or dogs.

Jenni Vartiainen is a researcher in Helsinki University. She is also founder of KIDE Science that is exporter of Finnish early childhood science education. This company is based on the research made Jenni and her team on young children using science and how they learn through play. KIDE is now taking over the world through early childhood science education using these Finnish methods.

Dr Carolyn Lam:                Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. I'm Dr Carolyn Lam, associate editor from the National Heart Center and Duke National University of Singapore. Dr Gregory Hundley:       And I'm Greg Hundley, associate editor from the Pauley Heart Center at VCU Health in Richmond, Virginia.                                                 Well, Carolyn, this week's feature is from Professor Carl Lindstrom from Helsinki University Hospital and the University of Helsinki and evaluates whether administration of simvastatin via nasogastric tube in brain-dead individuals prior to cardiac transplant donation improves transplant recipient cardiac-related outcomes. It is a randomized trial using an inexpensive therapy, and I look forward to that discussion with Professor Lindstrom. How about we grab a cup of coffee and start off our discussion today. Dr Carolyn Lam:                All right, so here goes. The first paper that I want to discuss really looks at the question, is DNA methylation related to incident coronary heart disease? Well, Dr Agha from Columbia University in New York and colleagues looked at this and profiled epigenome-wide blood leukocyte DNA methylation in 11,461 individuals from nine population-based cohorts in the United States and Europe using the Illumina Infinium 450K microarray and prospectively ascertained coronary heart disease events. Dr Gregory Hundley:       So Carolyn, what did they find? Dr Carolyn Lam:                Well, they found that differences in blood leukocyte DNA methylation at 52 cytosine phosphate guanine sites were associated with incident coronary heart disease or myocardial infarction with a false discovery rate of less than 0.05. Several of the differentially methylated loci mapped to genes related to calcium regulation and kidney function. Exploratory analyses with Mendelian randomization supported a causal effect of DNA methylation on incident coronary heart disease at loci in active regulatory regions with links to noncoding, RNAs and genes involved in cellular and tissue structural components.                                                 Very nice Caroline. So what's the summary for us clinically? Dr Gregory Hundley:       So, these findings really provide the first evidence that genomic regulation via epigenetic modifications in kidney function and calcium homeostasis related pathways may be involved in the development of coronary heart disease. The findings of epigenetic, loci related non-coding RNAs highlight pathways that have not immersed in genome-wide studies of coronary heart disease and therefore represent novel therapeutic targets, which thus far have not been explored. Dr Carolyn Lam:                Very good, Caroline. Well, I've got a basic paper that I want to present and it's from professor Xander Wehrens from the Baylor College of Medicine. And this study addresses factors that promote atrial fibrillation. The investigators found that reduced levels of protein phosphatase-1 regulatory subunit R3A in human atria are causally linked to abnormal calcium handling and atrial fibrillation pathogenesis.                                                 In the absence of protein phosphatase-1 regulatory subunit R3A reducing binding of PP1 catalytic subunit increases phosphorylation levels of the ryanodine receptor, R2 calcium release channel, and phospholamban. Complex zone, profiling, a technique that combines native gel electrophoresis with mass spectrometry to obtain the composition of multi protein assemblies revealed that PP1 R3A is part of a macro molecular protein complex containing the ryanodine calcium release channel and the circuit 2APLN calcium uptake transporter. Dr Gregory Hundley:       Wow. Complex zone profiling. That's so cool, but what does it all mean for us clinically, Greg? Dr Carolyn Lam:                Well reduced levels of PP1 regulatory subunit contribute to abnormal calcium release and re-uptake and atrial monocytes, thereby promoting atrial fibrillation pathogenesis. And thus normalizing levels of PP1R3A phosphatase sub unit may represent a novel therapeutic approach to manage atrial fibrillation. Dr Gregory Hundley:       That's so cool. I next have a preclinical paper which contributes really to the understanding of molecular basis of pathological myocardial remodeling in heart failure. And this is from co-corresponding authors, doctors, Jung, Liu, and Lin-Jung from Shanghai East Hospital Tongji University School of Medicine in China. And the paper really focused on Forkhead box transcription factor P1 or Foxp1 in endothelial cells. Dr Carolyn Lam:                So Foxp1 Carolyn, tell me a little bit more about that. Dr Gregory Hundley:       Is it good that you asked before I asked you. Forkhead box proteins P or Foxp are large modular transcription repressors that bind to DNA via their highly conserved Forkhead DNA binding domains. Fox p1 is highly expressed in vascular endothelial cells and it's essential for normal cardiac development.                                                 So, these authors found significantly down regulated Fox P1 expression in cardiac endothelial cells during cardiac remodeling induced by to angiotensin 2. Endothelial cell Fox P1 loss of function resulted in cardiac dysfunction following angiotensin 2 infusion and in the transverse aortic constriction model with severe cardiac fibrosis and mild adaptive cardiac hypertrophy.                                                 Whereas endothelial cell Foxp1 gain of function protected against pathological cardiac remodeling and improved cardiac dysfunction transforming growth factor beta 1 signals were identified as Foxp1 direct target genes in endothelial cells which mediated the pathological cardiac fibrosis through cardiac fibroblasts proliferation and myofibroblast formation and maladaptive cardiac hypertrophy through TGF beta 1 promoted endothelial one expression during pathological cardiac remodeling. Dr Carolyn Lam:                Wow. Carolyn, this was very sophisticated work. What do we take away from it clinically? Dr Gregory Hundley:       These data really identified endothelial Foxp1 mediated TGF beta 1 signal pathway involvement in the promotion of cardiac fibrosis and cardiac hypertrophy via TGF beta 1 induction of the endothelin one pathway. So targeted delivery of TGF beta 1 silencing RNA or small interfering RNA to inhibit endothelial cell specific TGF beta 1 for the improvement of pathological cardiac remodeling may actually represent a future novel therapeutic strategy in managing this maladaptive cardiac fibrosis and hypertrophy during progression of heart failure. Dr Carolyn Lam:                That was an excellent summary of a very technical but informative basic science paper. I'm going to shift gears a little bit and talk a little bit about a study relating to clopidogrel and aspirin from the point study.                                                 This study comes from Claiborne Johnston at the Dell Medical School and University of Texas. And in patients with acute minor ischemic stroke or high risk transient ischemic attack enrolled in the point trial. The combination of clopidogrel and aspirin for 90 days reduced major ischemic events but increased major hemorrhage compared to aspirin alone. This current paper is a secondary analysis of Point and involves 4,881 subjects in which the investigators assess the time course for benefit and risk from the combination of clopidogrel and aspirin.                                                 The primary efficacy outcome was a composite of ischemic stroke, myocardial infarction or ischemic vascular death, and the primary safety outcome was major hemorrhage. Risks and benefits were estimated for delayed times of treatment initiation using left truncated models. Dr Gregory Hundley:       So, what did the study show Greg? Dr Carolyn Lam:                Well through 90 days, the rate of major ischemic events was initially high, then decreased markedly while the rate of major hemorrhage remained low but stayed constant throughout the study. Using a model based approach the optimal change point for major ischemic events was 21 days with a hazard ratio of 0.65 for clopidogrel aspirin versus aspirin at a P value of 0.0015 compared to later at 22 to 90 days. Where that hazard ratio was 1.38 and the P value only 0.24.                                                 And the models showed benefits of clopidogrel aspirin for treatment delayed as long as three days after symptom onset. So Carolyn, the authors conclude that the benefit of clopidogrel aspirin occurs predominantly within the first 21 days and outweighs the low but ongoing risk of major hemorrhage. When considered with the results of the CHANCE study, a similar trial treating with clopidogrel aspirin for 21 days and showing no increase in major hemorrhage. The combined results suggest limiting clopidogrel aspirin use to 21 days may maximize benefit and reduce risk after TIA or minor ischemic stroke. Very practical paper. Dr Gregory Hundley:       Indeed. Thanks Greg. That was nice. Dr Carolyn Lam:                You bet. Dr Gregory Hundley:       Welcome everyone to our podcast and we're very pleased today to have Dr Antti Nykänen from Helsinki University in Finland as well as an associate editor, Justin Ezekowitz from Edmonton, Canada to discuss a very interesting randomized clinical trial related to the administration of simvastatin in those that are donors for heart transplantation and looking at subsequent outcomes in the patients that received the transplants. Antti, we're very excited for you to bring this to circulation. This particular paper and I wonder if you might outline for us what were your hypotheses that you are trying to test and what was your overall study design. Dr Antti Nykänen:            These things are routinely admitted to heart transplant recipients starting one to two days after transplantation. As previous clinical studies show that recipient that treatment has beneficial long-term effects on mortality and cardiac allograft vasculopathy. So in this clinical study, we basically tried to answer the question whether having the statin effect on the board even earlier before the transplant procurement by giving statins to the organ donor, if that would protect the transplanted hearts.                                                 And this question was based potential rapid vascular and cardioprotective effects of statin and when our previous experimental study showing that treating the organ donor with statins will decreases vascular profusion injury in a heart transplant model. So basically we went on the test donor simvastatin clinically and randomize brain dead heart transplant donors either to a control group or to receive a signal 80 milligram dose of simvastatin before organ procurement. Dr Gregory Hundley:       I'm imagining that you would administer the simvastatin through either an intravenous mechanism or perhaps an NG tube, something like that. Maybe tell us a little bit about how you accomplish this and then what were your study results? Dr Antti Nykänen:            So, the simvastatin was administered to the donor via a nasogastric tube so there is no intravenous simvastatin formulation available. It needs to be absorbed and then activated through the liver so that can form. So, what we did in our previous experimental study was that we included a few clinical human brain-dead donors and basically investigated whether by giving simvastatin through the nasogastric tube would be metabolized and if you could detect that in in the donor plasma.                                                 And that was actually the case. So in a few hours we saw up-regulated levels of simvastatin and also the active form in the donor or so basically showing off that treatment in a clinical brain dead donor of situation would be feasible. So we went on to use that method, clinical study and basically our primary outcome was plasma levels of cardiac injury biomarkers after transplantation.                                                 And interestingly by treating the donor with simvastatin decreased and recipients for troponin INT levels six hours after transplant's profusion. Therefore, it seems that organ donor’s statin treatment reduces biomarkers of myocardial injury after transplantation in a clinical setting. Dr Gregory Hundley:       And did you examine any other functional measures of these patients? For example, ejection fraction by echo or anything, or was it primarily a biomarker study? That's the first question. Second question. Do you have any other information on other organs that also may have been donated? Would the statin have impacted, for example, liver transplantation? Dr Antti Nykänen:            That's a good question. So we did follow up cardiac function and the routine and serial measurements with the echocardiographic and we did not find any changes in the left ventricle. It took some traction after transplantation.                                                 We did however find the decrease in proBNP levels into recipients. And that was maybe then at one week after transplantation and then it's leveled out after that.                                                 And then regarding the next question about other transplanted organs. So once he was in a multi organ donor situation, so the same donor could have donated kidneys or livers, lungs, pancreas. So we did a follow up of the close recipients also. And I can say that there was no adverse effects, no decline in the survival or primary function of the transplanted organs. And interestingly we did find in the liver recipient that if the recipient received the liver from a donor simvastatin treated the liver function tests were better at day seven post-transplant. Dr Gregory Hundley:       Very interesting. And then lastly, just another outcome related question. Sometimes I know these patients undergo assessments for rejection by biopsy. Any information that you can share with us on outcomes related to biopsies. Dr Antti Nykänen:            We took routine biopsies, myocardial biopsies from the recipients and we did not find any significant differences in the biopsy program rejections either at 30 days or one year after transplantation. We did also monitor, we checked some treatments, so during the first 30 days there was significant decrease in the amount of rejection treatments for hemodynamically rejects it about not for the first year. Dr Carolyn Lam:                Wow. Just fabulous results. Thank you so much Antti. So Justin, I wanted to turn the conversation over toward you. Tell us about post-transplant management of these patients and then how do you see these study results integrating into our current standards of care. Dr Justin Ezekowitz:        Thanks Greg and Dr Nykänen and thanks for also letting us look at your work, which is terrific and extremely hard to do from the translation of your original 2011 circulation publication in animals and moving forward into the current publication years later. And thinking forward into the next few years of how we translate this into practice so that the current management after transplantation obviously involve multiple anti-rejection medications and many activities around detecting rejection is one of the key ways in which patients are managed other than their hemodynamics and other things that happen early.                                                 What I was interested in is the generation of the idea where the simvastatin will really affect the clinical outcomes on the recipient and thinking that into the practice environment is, it's a very simple intervention to think about that would be easily applicable in, I think, most hospitals that do transplantation as either the recipient or the donor.                                                 And Dr Nykänen, when you think about translating this into practice over either Europe or in Finland, I don't sense that this is going to be very difficult. Statins are well tolerated. The cardiology and other communities are very familiar with using a statin. But do you anticipate any barriers to translating this into practice as I think the guidelines may pick this up as something of interest. Dr Antti Nykänen:            Yes, I think we can show that it's feasible and we did a result on the biomarkers, so indicating that the damage the heart undergoes during the transplantation was smaller after donor statin treatment, so it is feasible, it's very cheap and it generally has a good safety profile. The timeframe for the treatment also feeds into the window of creating a brain dead organ donor. So in that sense it would be applicable in a donor treatment situation. Dr Justin Ezekowitz:        Right. And so I think this is the key point is even though it's a smaller trial in terms of the cardiology thinks about its trials. This is an area that doesn't have a lot of clinical trials were randomized clinical trials and so any evidence of benefit with a known, generally considered safe medication such as a statin, you would think that we should be able to broadly apply pretty quickly even on what are often not hard outcomes that are softer outcomes.                                                 Because the benefit to risk ratio is generally favorable here. Dr Nykänen, my only other question to you is to think about the team getting this done must have been incredibly hard, but do you think there is a need for a larger trial to test this hypothesis on clinical outcomes or do you think this is really as far as you can go in the transplant world for an RCT. Dr Antti Nykänen:            So, it's been a long road from artery to single center clinical trial, which took time, so the patient numbers are fairly small in our study. We had 42 in the control group on 42 in the treatment group. I agree the risk benefit ratio is probably beneficial. But for sure it would be very nice to see larger studies that would look at the biomarker effects, but also would look at the other clinical end points. Dr Justin Ezekowitz:        Right, and that's a great point. It's only 84 patients, but a continued study of the area's important while perhaps implementation studies could go on to take what you found in both an animal translation into humans in a single center RCT and now translation into a larger population of recipients and their donors. I think that's probably the key next step in the transplantation world which has a tougher time getting larger number of patients into clinical trials for a variety of reasons.                                                 So, congratulations to you and your team in getting this one to the point where we could probably apply this in a reasonable way with reasonable safety and an expected benefit to a broader group of patients. Dr Gregory Hundley:       Well this has been a fascinating discussion, Antti as well as Justin and what a relatively simple, clever idea that could have profound outcomes for this transplant population. We certainly want to thank you Antti for bringing this to circulation and sharing it with our readership. Are there any few last words you'd like to share with us before we close today? Dr Antti Nykänen:            Very nice to see how things evolve after this. We will for sure try to look more closely at the mechanisms and follow up the patient population for a long term follow up. And I hope this will stimulate some other experiments in the field. Dr Gregory Hundley:       Justin, any parting comments from the editorial team? Dr Justin Ezekowitz:        This is a great example of a full clinical trial that is mechanistic, but also has MR outcomes, and I just want to congratulate the authors on providing a very full picture of all the pieces that it takes to do in a clinical trial environment. Plus also collecting genetic and other biomarker material and imaging material. So, my compliments to the authors both to yourself, Dr Nykänen, but also the team that you assembled over the last six or eight years of doing this project, which we know was a huge task and my congratulations to you and your team. Dr Gregory Hundley:       We want to thank Dr Nykänen and his team from Finland and Justin Ezekowitz. We look forward to chatting with you next week. Dr Carolyn Lam:                This program is copyright American Heart Association, 2019

The i's are all dotted and the t's crossed on the new cabinet and the government programme put together by Antti Rinne's five-party coalition. But what does it all mean in practice for ordinary people and how easy will it be for the administration to make good on its proposals? Political commentator Sini Korpinen and Helsinki University world politics professor Teivo Teivainen join APN to unpack the latest developments.

In Episode 7 of Series 2 Finnish architect and former Professor  of Architecture at the Helsinki University of Technology, Juhani Pallasmaa, explains how art and multi sensory awareness lie at the heart of architecture, based on vision and sensing not as automatic mechanisms but cultural matters we learn during childhood, and how seening the mind and body as a continuum and architecture as a verb not a noun is central to his teaching, practice and research.

Voters in Finland seem to be taking European Parliament elections seriously, as the latest figures show a bigger advance turnout than in 2014. All Points North looks at what's firing voters up, whether they're cooling on populist parties, and how the new parliament in Brussels could affect their future. Helsinki University world politics professor Teivo Teivainen and writer, activist and fearless commentator, Maryan Abdulkarim join the discussion. 24 May / All Points North / Yle News

Can one device eliminate your jet lag forever? Jari Koponen discusses the value of the Human Charger in battling the winter blues and jet lag. Who is Jari Koponen? Jari Koponen is a Brand Ambassador of HumanCharger. Before joining HumanCharger in 2014, Jari spent more than a decade in different roles in the automation industry delivering and taking care of systems in the mining sector. After that, between 2012 and 2014, he was full time at home with kids. While Jari very much enjoyed the global mining business, it was the constant long haul traveling that eventually motivated Jari to change the direction of his career. For a period of time, the opportunity to travel the world and to visit exotic mines (gold, copper, platinum, and others) in some of the most remote places on earth felt like a privilege for Jari but eventually the almost never-ending jet-lag and long stretches away from home was not worth the effort. Nevertheless, it was that first hand experience with the jet lag that connected Jari with the HumanCharger. When Jari had an opportunity to use the HumanCharger in 2013, while travelling cross 9 time zones, his experience with that "strange device" was so positive (he felt hardly any jet lag!) that after the trip, Jari made it clear to the HumanCharger team that he wants to join them and go out to tell everyone what an amazing device HumanCharger is. And since then Jari has been on mission! In his role at HumanCharger, Jari is responsible of the marketing efforts (among other things) and you can find him for example at HumanCharger booth at conferences around the world. Jari has a Master of Technology degree in Electrical Engineering from Helsinki University of Technology (today Aalto University, Finland) and MBA from Helsinki School of Economics (also today Aalto University). Jari lives in Switzerland with his wife, two kids and a puppy. Highlights [5:32] How big is the winter blues issue? [8:05] Winters in Finland [12:35] The origins of Valkee [13:45] How does the Human Charger work? [20:33] The significance of 12 minutes [23:24] Why shine lights in your ears? The role of opsin [33:08] UVB light [37:30] Tackling jet lag [50:13] Jari answers the final questions Resources The Human Charger The Human Charger Wireless Headset Human Charger Research Human Charger Travel App The Monk Who Sold His Ferrari by Robin Sharma Your Brain at Work by David Rock Continue Your High Performance Journey with Jari Kopenen Jari on Twitter Jari on Instagram Human Charger website Human Charger Instagram Sponsor Our sponsor for today’s show is one of the two brands of blue light blockers that I actually recommend using. I’ve had the CEO Matt Maruca on the show before and we got into a two-hour long discussion, which I think to this day is the longest episode of the Decoding Superhuman podcast. But his company raw optics has made blue light blockers sexy. And the beauty of their product is that blue light doesn’t get in. If any amount of blue light gets in, that Netflix show you’re watching late at night, that book that you’re reading on your iPad, that email that you’re answering, is disrupting your sleep. So where do you get yours? Head over to raoptics.com? plug in the code Boomer you’ll get 15% off your order. Disclaimer This information is being provided to you for educational and informational purposes only. This is being provided as a self-help tool to help you understand your genetics, biodata and other information to enhance your performance. It is not medical or psychological advice. Virtuosity LLC is not a doctor. Virtuosity LLC is not treating, preventing, healing, or diagnosing disease. This information is to be used at your own risk based on your own judgment. For the full Disclaimer, please go to (Decodingsuperhuman.com/disclaimer). See acast.com/privacy for privacy and opt-out information.

In March of this year, dr. Elisa Uusimäki from Helsinki University gave a presentation at a joint seminar hosted by Religious History, Old and New Testament Studies and Jewish Studies, at CTR, under the title"Wisdom and Torah in Jewish Antiquity: What Can We Learn from the Dead Sea Scrolls?"  Dr Elisa Uusimäki is a scholar of ancient Jewish literature and holds the title of docent at the University of Helsinki, currently involved in the research project "Conceptions of Virtue in Early Judaism" (2018‐2020). Uusimäki has published on wisdom and torah, the Dead Sea Scrolls, ancient scriptural interpretation, the figure of the sage in antiquity, and exemplarity. Apart from Helsinki, she has studied and conducted research at the University of Manchester, Yale University, Hebrew University of Jerusalem, and Rijksuniversiteit Groningen. The seminar focused on the association between wisdom and torah. Their prevalance and relation in the Hebrew Bible and the Septuagint is well‐ known (esp. Deut 4:5–6; Ezra 7:14, 25; Jer 8:8; Pss 1, 19, 119; Sir 24; Bar 3:9–4:4), and scholars have long acknowledged its afterlife in the thought of early Christians who identified Jesus with Logos or Sophia (e.g. John 1, 15; 1 Cor 1:24, 30; Col 1:15‐17, 2:2‐3). The discovery of the Qumran scrolls revealed new materials that illuminate notions of wisdom and torah in early Judaism. ----------------------------------------------------------------------------------------------- Religion and Theology is produced by Joel Kuhlin for the Center for Theology and Religious Studies. If you have comments or critique of this episode, or any other episodes of R&T, please write an email to religionochteologi@outlook.com. ----------------------------------------------------------------------------------------------- Music for R&T is generously provided by the trio Nous (Thomas Hellsten, Tom Tveita, Per Boqvist).

New legislation underway will make it easier for small firms to fire workers, and unions are pulling no punches to try and stop what they see as the erosion of workers' rights. Meanwhile food courier workers are up in arms over an ultimatum to sign up for reduced pay -- or hit the road. Our guest on All Points North this week is digital economy labour researcher Ville-Veikko Pulkka from Helsinki University. 5 October / All Points North / Yle News

Do dark days affect your energy levels? Is your best harder to achieve when winter comes? The CEO of Light Cognitive, Sami Salomaa reveals how his lights reduce the symptoms of Seasonal Affective Disorder and optimize your life by synchronizing your days. Find the show notes here — Decoding Superhuman.com/LightCognitive   “In South Africa, I had a room facing into the Indian Ocean. I would wake up early in the morning, with the sunrise. It was excellent. They spoke about the green flash. So, I woke up every morning to see if I could see the green flash. I'm not sure if I ever saw it but the point is something like this burns into your head. You think this is what mornings should be every time.”   Who is Sami Salomaa?   Sami Salomaa is the founder of Light Cognitive, a startup that designs unique lighting solutions dedicated to well-being and performance.   Prior to starting Light Cognitive, Sami worked for eight years at Nokia CFO office in New York. He has extensive experience in building innovative and complex business models at the crossroads of finance and technology.   After returning to Helsinki and Nordic weather conditions he realized how fundamental the role of light is for our holistic well-being, alertness, and recovery. Basing his innovation on physics models he started developing a solution for re-creating natural light in indoor spaces.   Sami is passionate about well-being and how technology can help people feel better and achieve more. His favorite recipe for well-being is a day skiing and a bright Alpine sky.   Sami graduated from the Helsinki University of Technology, with a Master of Science in Technical Physics and Applied Mathematics. He currently resides in Cambridge, UK, and examines the possibilities of AI.   What is the Light Cognitive?   Light Cognitive uses broad spectrum lighting to control when the day starts and when it ends. They solve year round circadian rhythm issue by activating melanopsin at the right times.   Key Highlights of the discussion with Sami Salomaa: Symptoms of Seasonal Affective Disorder (SAD) Circadian biology The benefits of full spectrum light How to get over jet lag How light influences the way plants grow The role Vitamin D plays in overcoming Seasonal Affective Disorder Achieving peak performance through better sleep The difference between Light Cognitive products and other offerings The studies of Harvard Medical School’s Dr. Steven Lockley, Ph.D. Sami’s Pet Peeves about the Medical Industrial Complex: Incenting medical professionals to increase medications and operations for financial rewards. Sami’s Tip for Enhancing Focus: Shut out the world and get meditative. Sami Finds Inspiration in: The writings of Nassim Taleb Seneca’s writings Continue Your Performance Journey: Light Cognitive Light Cognitive Big Sky Big Sky Limitless Light Cognitive on Facebook Books on Peak Performance:   Antifragile Letters from a Stoic Fooled By Randomness — Nassim Taleb   My sponsor for this episode is the ring on my finger and yes, I’m not even married yet but I want to give a shout out to these guys because it has changed the way I look at sleep. Oura Ring helps me track the way I sleep. The information it gives me is absolutely essential to becoming a more epic human. I look at things like REM sleep, deep sleep, my sleep stages and the sequence of that. Listen to my podcast with Dr. Smarr if you want to realize what that all really adds up to. And I look just sort of lifestyle adjustments to make me sleep better. For instance, not eating so late at night leads to an earlier resting heart rate, leads to me feeling just more and more awesome the next day and it’s also impacted how I do things like intermittent fasting. So I hope you all check it out and if you want to check it out now, the guys at Oura are giving 50 dollars or 50 euros off depending on what part of the world you’re in. Visit OuraRing.com and plug in the code ‘BOOMER’ for that discount. See acast.com/privacy for privacy and opt-out information.

Have you heard of Industry 4.0? It's one of the "hype" terms describing the current industrial revolution where data, automation, robots come together.  Is Industry 4.0 already history?  How does a "factory as a service" look like?  Edward Blomstedt is the CEO of AirFaaS and has the goal to revolutionise manufacturing.  As "Youn Entrepreneur of the Year" in Finland, he has already an entrepreneurial track record.  Enjoy the episode. More about Edward Blomstedt What is the next Airbnb, the next Uber or Spotify? And who says it will be consumer-related? According to Edward Blomstedt, a Finnish entrepreneur, supported by investors, industrialists and top politicians, the breakthrough will be in business to business. And the service is spelled ”AirFaas”. Edward is one of the founders of the company, a digital portal where you can upload the specifications of any product in the system and it will analyze, locate, budget, finance and implement the production of the product at the most competitive prize and in the most convenient format in a factory somewhere in the world. An Airbnb for factories. Edward has an M.Sc. in Industrial Management and Mechanical Engineering from Helsinki University of Technology (now Aalto University). His passion is enabling a smarter revolution in manufacturing for a greener future. He was voted Young Entrepreneur of the Year in Finland 2010. Edward also started the company Combi Works 2005, which works in the conservative industrial sector and is now revamping this with AirFaas. Combi Works has sales in Northern Europe and Uganda and production in addition to Finland in the Baltics, Russia, China and India. How to connect with Edward Twitter: http://twitter.com/edwardblomstedt LinkedIn: https://fi.linkedin.com/in/edwardblomstedt Website: www.airfaas.com    

Dr. Tuomo Suntola is a co-owner and Board Member of the Finnish atomic layer deposition technology company Picosun Ltd. He is also Chairman of the Finnish Society for Natural Philosophy, Chairman of the Physics Foundations Society, and author of the books The Short History of Science, The Dynamic Universe, and Theoretical Basis of the Dynamic Universe. Most of Tuomo’s career has been spent working on a technology called atomic layer deposition (ALD). This technology is based on a saturated reaction that occurs on the surface of a material that allows the production of highly ordered material layers one atomic layer at a time. These layers are essential for the modern integrated circuits that are found in all of our electronic devices, but they are also used for various other applications including solar cells, lithium ion batteries, luxury watches, coins, and telescope mirrors. In addition to ALD technology, Tuomo is passionate about studying fundamental physics as well as the philosophy and history of science. When not thinking about technology, science, or the philosophy of science, Tuomo enjoys spending time with his family and friends, taking care of his home and garden, and having a refreshing swim in a the swimming hole near his home. He was awarded his M.S. and PhD in electrical engineering from the Helsinki University of Technology where he studied semiconductor physics. Afterwards, Tuomo worked as a Scientist at the VTT Technical Research Centre of Finland for a few years before accepting a position as Chief Scientist at Instrumentarium Ltd. He subsequently served as Director of Display Division and Chief Scientist at the consumer electronics manufacturing company Lohja Ltd, Managing Director of a subsidiary of the national oil company Neste Ltd. called Microchemistry Ltd, a Research Fellow in the national energy company Fortum Corporation. After retiring from Fortum, Tuomo has continued in his roles at Picosun. Over the course of his career, Tuomo has received many awards and honors, including the 2004 European SEMI Award for pioneering atomic layer deposition techniques. He was also honored in 2018 with the Millennium Technology Prize, which is regarded as Finland’s Nobel Prize, for developing this atomic layer deposition technology. He is an elected Member of the Finnish Academy of Technology, was a Member of a World Energy Council working group from 2003-2004, and was named a Knight First Class of the Order of the Lion of Finland. In our interview, Tuomo shared more about his life and science.

Sami Inkinen is the CEO & Founder of San Francisco based Virta Health. Virta is an online specialty medical clinic that reverses type 2 diabetes safely and sustainably, without the risks, costs, or side effects of medications or surgery. Sami is also an active investor in companies advancing human health and performance as an angel investor and Venture Partner at Obvious Ventures. Previously, Sami was a co-founder, COO and President of Trulia until it’s IPO and eventual sale for $3.6B. Sami, an avid athlete, is a triathlon world champion in his age group, and recently rowed across the Pacific Ocean from California to Hawaii unsupported with his wife at a record speed to raise awareness about healthy nutrition. Sami received his Masters in Physics from the Helsinki University of Technology and MBA from Stanford University. The last time Sami and I spoke in the podcast , we discussed how Sami has a busy work life that only allows him a maximum of about 12 hours per week to train, and in that interview, he revealed his secrets, including: -What 99% of Ironman triathletes do wrong… -How a typical week of Sami’s triathlon training goes… -Sami’s top swim sessions and strategies (including the use of a )… -How the combination of indoor cycling and a  can save you tons of time... -Sami’s top run workout on the track… -How Sami uses something called  to track recovery, and what he really thinks about other training recovery tools… -What Sami eats and what he avoids eating… -And much more! Now Sami's back, and during our discussion, you'll discover: -The story of Sami's crazy low-carb rowing adventure to Hawaii, fueled by dehydrated vegetables, jerky and nuts...8:30 -What Sami's been up to with the creation of Virta Health...18:15 -How Virta Health works in a shockingly effective way to reverse Type II diabetes...26:45 -How Sami is quantifying his health, his sleep, his fitness and other lifestyle parameters...34:00 -What Sami's diet looks like now...42:30 -Dr. Steven Phinney's thoughts on the dangers of fasting...48:00 -The supplements Sami takes or does not take for maintaining a low-carb lifestyle, anti-aging and beyond...52:00 -And much more! Resources from this episode: - - - - Episode Sponsors: offers "A Better Way to Cook!" Enjoy a savings of $30 off your first order using our !       : If you've had a difficult workout the day prior or you're excessively sore, pop 4-6 Kion Flex on an empty stomach – preferably in the morning on an empty stomach. If your stomach isn't empty in the morning because you're an early eater, simply save this supplement for the evening and take it before bed. Use coupon code "benflex10" and receive 10% off your order!           Enjoy increased sexual performance with Gains Wave for men, and Femi Wave for the ladies! Get 30% off your first treatment using our special links.   .             Get lower health insurance rates if you’re conscious of your health! Visit for a free quote.     Do you have questions, thoughts or feedback for Sami or me? Leave your comments at http://bengreenfieldfitness.com/sami2 and one of us will reply!

On June 6, Espoo was named as the 2018 Intelligent Community of the Year. Prior to the Summit, and before knowing his community would be named Intelligent Community of the Year, Mayor Jukka Mäkelä spoke with Lou Zacharilla about Espoo. Jukka Mäkelä was born in Espoo, Finland in 1960. In 2007 Mäkelä was elected as a Member of Parliament for the National Coalition Party. Mäkelä has been the Mayor of Espoo since the start of 2011. He has been involved in the local politics of Espoo as a City Counsellor since 1997, as Chair of the City Board years 2005–2008, and as Chair of the City Council 2009–2010. He gained a degree of Master of Science in Technology from the Helsinki University of Technology.

Welcome to Attachment Theory in Action! Our podcast is dedicated to therapists, social workers, counselors and psychologists who are working with clients from an attachment-based perspective. Interviews are conducted with individuals who are doing clinical work as well as leading attachment theory researchers. Your host, Karen Doyle Buckwalter will introduce you to Saara Salo. Saara Salo is a clinical psychologist at the Helsinki University Central Hospital in Helsinki, Finland. She received her Ph. D. in developmental psychology from Helsinki University. In addition, Saara is a Theraplay-certified trainer, therapist, and supervisor, and a licensed Systemic Family Psychotherapist as well as a licensed Psychodynamic Parent-Infant Psychotherapist. Saara gives over 40 lectures or workshops per year in Finland, Norway, Denmark, the Netherlands, Turkey, and the UK. 

This week APN looks at Helsinki University professors and other staff who walked off the job to protest failed wage negotiations, hockey fans talk about beer drinking in sports arena stands in light of new alcohol laws, and we discuss the idiosyncracies of Finnish etiquette. Our special guest is Teivo Teivainen, a Helsinki University Professor of World Politics. 2 March 2018 / All Points North / Yle News

Rob and Jason are joined by Jussi Pakkanen to discuss the Mesonbuild multiplatform build system for C++ Jussi Pakkanen got his doctoral degree in computer science from the Helsinki University of Technology in 2006. Since then he has worked on various problem areas ranging from mail sorting to the software stacks of Ubuntu desktop and phone. Most recently he was the SDK lead developer at Jolla. Currently he is open for new development challenges. During his spare time he has been known to be a photographer, movie director, magician, gastronomist, computer game designer and watercolour painter. News Under the Hood: Leap Motion Hackathon's AR Workspace STL Fixes in VS 2015 Update 1 Meeting C++ Lightning talks are now on youtube Jussi Pakkanen Jussi Pakkanen's blog @jpakkane Links Mesonbuild Mesonbuild on GitHub Making build systems not suck